valueequityanalysis.com

Independent, business-by-business valuations built from company filings — owner earnings, a ten-year outlook, and a bear / base / bull range. Search a ticker to see our estimate of what the business is worth.

Not investment advice. We are not registered investment advisers, and the people behind this site may hold or trade positions in companies analyzed here. Full disclosures.

Accelerant Holdings (ARX) stock intrinsic value fair value estimate & owner earnings analysis

Margin of safety$0.60 ComplexityHigh Updated
$0.00 $5.73
bear $0.00 base $1.17 bull $5.73 margin of safety $0.60 market price* $19.75
Business condition attached to the margin of safety Owner earnings (operating cash earnings after stock compensation and technology spending, before insurance float swings) stay clearly positive for at least three consecutive quarters, confirming the strong second quarter of 2026 was not a one-off.
Accelerant Holdings runs a technology-driven marketplace for specialty insurance (the Risk Exchange). It connects 280 underwriting businesses (Members) with 95 outside capital providers (Risk Capital Partners), placed $4.19 billion of premium across 22 countries in 2025 (up 35%), and earns money three ways: volume-based fees from capital providers, commissions from Members it owns or controls, and the underwriting result and investment income on the slice of risk it keeps. It listed in July 2025, so the filings give only three fiscal years. How we measure earnings. Reported operating cash flow ($445 million in 2025) is dominated by insurance float: premiums collected before claims are paid ($397.8 million of the 2025 figure came from working-capital movements such as growth in unpaid claims, unearned premiums and funds held). That is borrowed money, not owner profit, so we strip it out, then subtract stock compensation ($43 million non-cash in 2025) and the part of technology spending needed to keep the platform running (about $21 million of $41 million capitalized). On that basis owner earnings were about -$16.8 million in 2025 (-$0.09 per share), -$41 million in 2024 (-$0.21) and -$104 million in 2023 (-$0.63): improving each year but still negative. The 2025 reported net loss of $1.35 billion is almost entirely a one-time, non-cash charge tied to the IPO ($1.38 billion of profits-interest distribution) and does not affect the value estimate. We did not use the company's adjusted profit measures. Borrowings (about $121 million) are operating funding for an insurance business, so we value earnings after interest and deduct no separate debt. What changed in 2026. Revenue rose 59% in the first half of 2026 to $630 million and the second quarter was clearly profitable (net income of $80 million, of which $27 million was unrealized investment gains we exclude), while the first quarter was roughly break-even. Our rough estimate of first-half owner earnings is about +$59 million, nearly all in the second quarter, but stock compensation is running near $100 million a year and operating cash flow was -$90 million for the half as premium receivables and reinsurance balances absorbed cash. One strong quarter is not enough to reset the earnings level. Base case: $1.17 per share. The earnings level is the average of the 18 months since the IPO (the 2025 loss and the strong first half of 2026), about $28 million a year or $0.12 per share on roughly 221 million shares. We credit no growth: fee volume has grown fast, but only over a few years, with no downturn in between, and the specialty insurance market is not guaranteed to keep expanding. Year-one growth is therefore held flat versus the trailing figure. The level is assumed to persist for 15 years, supported by the platform's contracted Member and capital-provider relationships, then it ends because no evidence supports a longer life. The business is worth about $1.17 per share; borrowings are treated as operating funding, so nothing is deducted. Bear case: $0. Owner earnings stay near zero to negative as they were in each of 2023 to 2025 and in the first quarter of 2026: rising stock compensation and technology spend absorb the fee and underwriting profit, and the business is worth nothing to shareholders on the evidence. Named risks: the company cedes a large share of its premium to reinsurers (billions of reinsurance recoverables), so a reinsurer or capital-provider pulling back would hurt the model; and a softening specialty market would cut fees. Bull case: $5.73 per share. The second-quarter 2026 run-rate (about $0.50 per share a year, after stock compensation and maintenance technology spend) holds for 20 years as Risk Exchange Insurers write more of the premium and fee revenue replaces underwriting risk. No further growth is credited. Margin-of-safety price: $0.60, about half of the base case, because the bear case is worth nothing, the company has a short record, and its earnings only recently turned positive. The price also assumes confirmation that the second quarter was not a one-off. What would make this wrong: sustained positive owner earnings above about $0.25 per share for several quarters (the base and bull would be too low), or reinsurance and float cash strain that leaves the company needing new capital (the bear case would get worse). Stock compensation of $52 million in the first half of 2026 shows how much of any profit goes to employees. We could not fully separate how much of first-half 2026 owner earnings comes from one-time versus recurring items without the full quarterly statements.
Fiscal yearOwner's earningsMethodology
2025 -$0.09 ▼
OE = CFO - working-capital movement - SBC - maintenance capex. Insurer/risk-exchange (financial business: interest is an operating cost, no debt add-back). CFO=$445.1M; working-capital cash effect=+$397.8M (premiums receivable (258.6), ceded unearned premiums (225.9), reinsurance recoverables on unpaid losses (589.3), other reinsurance recoverables (219.3), DAC (15.7), unpaid losses & LAE +645.3, unearned premiums +287.3, payables to reinsurers +87.1, deferred ceding commissions +55.5, funds held +451.0, other assets/AP/other liabilities +180.4); SBC (non-cash add-back)=$43.1M; capex (capitalized technology development)=$41.4M, capex/revenue 3-yr mean 6.57%, revenue $912.9M vs $602.6M prior so growth capex=$20.4M, maintenance capex=$21.0M; OE=$445.1-397.8-43.1-21.0=$(16.8)M; diluted shares=190.260M (loss year, basic=diluted); OE/sh=$(0.088). Reconciliation: net loss $(1,345.2)M + profits-interest distribution expense (non-cash IPO charge) 1,379.7 + other non-cash items (net -32.5, incl. SBC 43.1, D&A 35.2, deferred tax (32.0), unrealized gains (39.4)) = CFO less working-capital $47.3M (exact). Source: FY2025 10-K, accession 0001997350-26-000003.
2024 -$0.21 ▼
OE = CFO - working-capital movement - SBC - maintenance capex. Insurer/risk-exchange (financial business: no debt add-back). CFO=$785.7M; working-capital cash effect=+$801.1M (premiums receivable (319.0), ceded unearned premiums (648.3), reinsurance recoverables (471.0), other reinsurance recoverables +7.5, DAC (8.2), unpaid losses +540.3, unearned premiums +674.8, payables to reinsurers +636.4, deferred ceding commissions +68.4, funds held +203.0, other assets/liabilities +117.2); SBC=$8.4M; capex (capitalized technology development)=$34.4M, capex/revenue 3-yr mean 6.57%, revenue $602.6M vs $344.0M prior so growth capex=$17.0M, maintenance capex=$17.4M; OE=$785.7-801.1-8.4-17.4=$(41.2)M; diluted shares=199.664M; OE/sh=$(0.206). Reconciliation: net income $22.9M + non-cash items (net -38.3 incl. SBC 8.4, D&A 26.6, deferred tax (40.9), unrealized gains (19.0)) = CFO less working-capital $(15.4)M (exact). Source: FY2025 10-K (comparative column), accession 0001997350-26-000003.
2023 -$0.63 ▼
OE = CFO - working-capital movement - SBC - maintenance capex. Insurer/risk-exchange (financial business: no debt add-back). CFO=$290.0M; working-capital cash effect=+$356.2M (premiums receivable (221.8), ceded unearned premiums (285.7), reinsurance recoverables (252.9), other reinsurance recoverables (162.0), DAC (19.3), unpaid losses +326.7, unearned premiums +377.0, payables to reinsurers +215.2, deferred ceding commissions +32.6, funds held +303.4, other assets/liabilities +43.0); SBC=$4.8M; capex (capitalized technology development)=$32.6M; prior-year (2022) revenue not available so growth capex not estimated and maintenance capex set equal to total capex (conservative); OE=$290.0-356.2-4.8-32.6=$(103.6)M; diluted shares=165.605M; OE/sh=$(0.626). Reconciliation: net loss $(64.1)M + non-cash items (net -2.1) = CFO less working-capital $(66.2)M (exact). Source: FY2025 10-K (comparative column), accession 0001997350-26-000003. Only three fiscal years exist in filings (company listed July 2025).

Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.

Sales geography
United States, Europe, United Kingdom, Canada and Australia (specialty insurance written across 22 countries, primarily the United States, Europe, Canada and the United Kingdom)
Historical growth strategy

We don't have historical growth strategy information for this company yet.

Chart analysis
Accelerant went public in July 2025, so its chart holds only about 14 months of trading history: too short to establish a long-term trend, multi-year support or resistance, or reliable moving-average behavior. A chartist would treat the IPO price as the key reference level, note that recent-IPO stocks often trade in a volatile, wide range while a base forms, and wait for a well-defined base before calling a trend. Until a longer track record forms, technical signals should be regarded as low-confidence.
Competitors

We don't have competitor information for this company yet.

Circle of competence

We don't have circle of competence information for this company yet.